At the time of writing, Evolus Inc [EOLS] stock is trading at $7.43, up 2.70%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The EOLS shares have gain 16.02% over the last week, with a monthly amount drifted -22.49%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Evolus Inc [NASDAQ: EOLS] stock has seen the most recent analyst activity on August 06, 2025, when Needham downgraded its rating to a Hold. Previously, BTIG Research started tracking the stock with Buy rating on April 17, 2025, and set its price target to $21. On January 29, 2024, upgrade upgraded it’s rating to Overweight and revised its price target to $16 on the stock. Needham started tracking the stock assigning a Buy rating and suggested a price target of $18 on June 23, 2022. Barclays upgraded its rating to a Equal Weight and raised its price target to $10 on May 12, 2022. Truist upgraded its rating to Buy for this stock on January 20, 2022, but kept the price target unchanged to $11. In a note dated May 06, 2021, Mizuho upgraded an Buy rating on this stock but restated the target price of $15.
For the past year, the stock price of Evolus Inc fluctuated between $5.71 and $17.82. Currently, Wall Street analysts expect the stock to reach $24 within the next 12 months. Evolus Inc [NASDAQ: EOLS] shares were valued at $7.43 at the most recent close of the market. An investor can expect a potential return of 223.01% based on the average EOLS price forecast.
Analyzing the EOLS fundamentals
According to Evolus Inc [NASDAQ:EOLS], the company’s sales were 277.94M for trailing twelve months, which represents an 3.70% jump. Gross Profit Margin for this corporation currently stands at 0.67% with Operating Profit Margin at -0.16%, Pretax Profit Margin comes in at -0.22%, and Net Profit Margin reading is -0.22%. To continue investigating profitability, this company’s Return on Assets is posted at -0.27, Equity is 17.91 and Total Capital is -0.26. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-9.83.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 7.23 points at the first support level, and at 7.03 for the second support level. However, for the 1st resistance point, the stock is sitting at 7.56, and for the 2nd resistance point, it is at 7.70.
Ratios To Look Out For
It is important to note that Evolus Inc [NASDAQ:EOLS] has a current ratio of 2.27. As well, the Quick Ratio is 1.86, while the Cash Ratio is 0.97. Considering the valuation of this stock, the price to sales ratio is 1.73.
Transactions by insiders
Recent insider trading involved Stewart Brady, Director, that happened on Aug 15 ’25 when 30000.0 shares were purchased. MOATAZEDI DAVID completed a deal on Jun 13 ’25 to sell 0.11 million shares. Meanwhile, MOATAZEDI DAVID sold 16582.0 shares on Jun 16 ’25.
